Thursday, September 15, 2016 Dechra Veterinary Products has received FDA-CVM approval for Amoxicillin Trihydrate and Clavulanate Potassium Tablets. This approval represents the first registration Dechra has achieved through Putney’s development pipeline since it acquired the US-based business earlier this year. Read more
Thursday, May 19, 2016 Dechra Veterinary Products has acquired Putney, Inc. Dechra has begun the process to integrate the two businesses together with the goal of creating one animal health company that provides high-quality veterinary products and delivers solutions to the problems veterinarians experience every day in practice. Read more
Monday, April 4, 2016 Dechra Veterinary Products has been awarded the National Animal Supplement Council's (NASC) Seal of Quality for its PHYCOX® joint health supplements for canine and equine patients. Read more
Tuesday, March 15, 2016 Dechra Pharmaceuticals PLC announces the acquisition of the entire share capital of Putney, Inc., a leading developer of generic companion animal pharmaceuticals in the US, based in Portland, Maine. Read more
Friday, March 4, 2016 Dechra Veterinary Products is pleased to announce FDA-CVM approval, and the availability, of Zycortal® Suspension (desoxycorticosterone pivalate injectable suspension). Desoxycorticosterone pivalate is a mineralocorticoid hormone approved for use as replacement therapy for mineralocorticoid deficiency in dogs with primary hypoadrenocorticism (Addison’s disease). Read more
It's free and only takes a few minutes.
Sign up today to gain access to wide range of materials supporting our Companion animal and Equine products.